GEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven novel precision medicines for immunology, inflammation, and rare diseases, today announced a strategic ...
DARPA's synthetic blood has worked in animal testing. Now, it must overcome regulatory and cost challenges to take it into ...
Real-world use of an MS blood test shows how it helps monitor disease activity and guide treatment decisions in U.S. patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results